Wedbush Has Pessimistic Outlook of NovoCure Q1 Earnings
NovoCure Limited (NASDAQ:NVCR – Free Report) – Wedbush lowered their Q1 2025 earnings per share estimates for NovoCure in a research note issued on Wednesday, April 16th. Wedbush analyst D. Nierengarten now expects that the medical equipment provider will post earnings per share of ($0.74) for the quarter, down from their prior estimate of ($0.71). […]
NovoCure Limited (NASDAQ:NVCR – Free Report) – Wedbush lowered their Q1 2025 earnings per share estimates for NovoCure in a research note issued on Wednesday, April 16th. Wedbush analyst D. Nierengarten now expects that the medical equipment provider will post earnings per share of ($0.74) for the quarter, down from their prior estimate of ($0.71). […]
